Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jun 18, 2024 8:43am

121 Views

Post# 36093600

RE:RE:RE:RE:News

To be more specific, it translates well in humans for NMIBC because the bladder cancer is accessible. What about the other indications? Can it be delivered in such a way that it permeates the tumor or cancer area? Do we know the answer to that? Maybe that's why the market shuns the developments the company announces, because it's too early? Not proven applicable to humans just yet? I obviously don't know. But there has to be some reason the market doesn't 'buy' these NRs.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec